Translational Research

Clinical Trials

Project Grants

Global Action Plan 4 - INTense Exercise foR surVivAL among men with Metastatic Prostate Cancer (INTERVAL – GAP4) 2016 - 2022
Preventing the Respiratory Failure Causing COVID-19 Mortality, Potent New Drugs Targeting Hyperinflammation 2020 - 2022
Upfront PSMA Alliance 2019 - 2021
Pilot study of diagnostic accuracy of PSMA PET/MRI, mp MRI, MRI USS fusion biopsy and 'prolaris' genomic risk stratifier 2017 - 2018
A novel liver targeted therapy for sarcopaenia in androgen deprived men with prostate cancer 2016 - 2018
Precision medicine in advanced and oligometastatic prostate cancer 2016 - 2018
TrueNTH - an integrated multi-component intervention to improve the lives of men with prostate cancer in Australia 2012 - 2018
Feasibility Study - Identification of prostate cancer recurrence sites by Gallium-labelled PSMA PET/MRI in patients with biochemical recurrence following definitive therapy 2015 - 2017
ADMET Random control trial to evaluate the prognostic and metabolic benefits of metformin during androgen deprivation therapy in metastatic prostate cancer 2014 - 2017
Precision medicine in advanced prostate cancer 2015 - 2016
Evaluation of Prostate-specific Membrane Antigen Based PET and MRI for the Detection of Multiple Cancer Foci in Localised Prostate Cancer Patients 2014 - 2015
Circulating Tumour Cells Collaborative Prostate Cancer Biomarker Project 2013 - 2014